跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MINT-TRIMEBUTINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
MINT-TRIMEBUTINE
Authorized
STANDARD
MINT-TRIMEBUTINE
mint pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
038439b895dccf5d
Company
mint pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
038439b895dccf5d
Drug Approval Canada Name
MINT-TRIMEBUTINE
Product Name
MINT-TRIMEBUTINE
Status
Marketed
Status Date
2024-01-17
Original Market Date
2024-01-17
Din
02538202
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:32.00
Atc Original
A03AA05 TRIMEBUTINE
Atc Name
a 03 aa 05
Aig Number
0115865003
Company Name
mint pharmaceuticals inc
Company Address
6575 Davand Drive, Mississauga, Ontario, Canada, L5T 2M3
Active Ingredients
TRIMEBUTINE MALEATE
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
038439b895dccf5d
Type
Standard
Back to Health Canada Approvals